David G. Coffey, MD
Seattle Cancer Care Alliance
University of Washington School of Medicine
Fred Hutchinson Cancer Research Center
Multiple myeloma, smoldering myeloma, Monoclonal Gammopathy of Undermined Significance (MGUS), plasma cell leukemia, AL amyloidosis, Waldenström macroglobulinemia
Why is oncology an ideal fit for you?
Specialties and clinical expertise
The branch of medicine a provider practices and their areas of focus
I specialize in treating patients with cancers of the plasma cell, a type of immune cell that lives in the bone marrow. Plasma cells make antibodies, our first line of defense against infection. When these plasma cells go wrong, often because of a mutation, they can develop into cancers such as multiple myeloma, Waldenstrom’s macroglobulinemia or amyloidosis. I see a large spectrum of patients with this subset of cancers, from the very young to the very old. I am also an attending physician on SCCA’s autologous stem cell transplant team.
In the lab, I focus on applying new technologies to better inform treatment decisions for patients with multiple myeloma. For example, I am investigating whether sampling tumor DNA in the blood can better inform us about the cancer’s biology. There are currently 19 drug therapies available for multiple myeloma, and knowing more about tumor mutations might help us choose which of those 19 will be best for a particular patient.
What is your approach to care and treatment?
University of Colorado, Denver
University of Colorado, Internal Medicine
University of Washington, Hematology and Oncology
Medical Oncology, 2015; Internal Medicine, 2012, American Board of Internal Medicine